AmbioPharm Acquired by CordenPharma | Healthcare M&A Deal

CordenPharma has acquired AmbioPharm, a medical devices business in South Carolina. CordenPharma acquisitions are aimed at expanding global peptide API capacity and improving supply for healthcare customers. The AmbioPharm acquisition supports peptide manufacturing capabilities tied to pharmaceutical ingredients and production scale-up, strengthening SC acquisitions in the healthcare M&A market. Announced as a merger acquisition and strategic acquisition, the healthcare deals SC transaction size remains undisclosed, with CordenPharma positioned as a strategic buyer pursuing capacity growth through merger acquisition rather than a financial recap.